Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Integration of clinical and transcriptomics reveals programming of the lipid metabolism in gastric cancer

Fig. 3

Validation the lipidomics signature in validation cohort. (A) Patient survival status and time distributed by lipid-score for each validation cohort; (B) the distribution of lipid score for each validation cohort; (C) K -M survival curve of the lipid-score for the OS time of each validation cohort. The dotted line indicates the individual inflection point of the risk score curve, by which the patients were categorized into low- and high-risk groups

Back to article page